These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19687747)

  • 1. Acute efficacy and safety of intravenous administration of nicorandil in patients with acute heart failure syndromes: usefulness of noninvasive echocardiographic hemodynamic evaluation.
    Minami Y; Nagashima M; Kajimoto K; Shiga T; Hagiwara N
    J Cardiovasc Pharmacol; 2009 Oct; 54(4):335-40. PubMed ID: 19687747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous nicorandil for treatment of the urgent phase acute heart failure syndromes: A randomized, controlled trial.
    Harada K; Yamamoto T; Okumura T; Shigekiyo M; Terada N; Okada A; Kawata A; Iima T; Harada T; Fujisawa K; Kageyama N; Saito A; Yamamoto H; Fujinaga H
    Eur Heart J Acute Cardiovasc Care; 2017 Jun; 6(4):329-338. PubMed ID: 26884620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in hemodynamic responses between intravenous carperitide and nicorandil in patients with acute heart failure syndromes.
    Hattori H; Minami Y; Mizuno M; Yumino D; Hoshi H; Arashi H; Nuki T; Sashida Y; Higashitani M; Serizawa N; Yamada N; Yamaguchi J; Mori F; Shiga T; Hagiwara N
    Heart Vessels; 2013 May; 28(3):345-51. PubMed ID: 22526380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure.
    Larsen AI; Gøransson L; Aarsland T; Tamby JF; Dickstein K
    Am Heart J; 1997 Sep; 134(3):435-41. PubMed ID: 9327699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of intravenous nicorandil on hemodynamics in patients hospitalized with acute decompensated heart failure.
    Tanaka K; Kato K; Takano T; Katagiri T; Asanoi H; Nejima J; Nakashima M; Kamijo T; Sakanashi M
    J Cardiol; 2010 Nov; 56(3):291-9. PubMed ID: 20709498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure.
    Lapp H; Mitrovic V; Franz N; Heuer H; Buerke M; Wolfertz J; Mueck W; Unger S; Wensing G; Frey R
    Circulation; 2009 Jun; 119(21):2781-8. PubMed ID: 19451356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of nicorandil therapy in patients with acute heart failure.
    Shirakabe A; Hata N; Yokoyama S; Shinada T; Kobayashi N; Asai K; Mizuno K
    J Cardiol; 2010 Nov; 56(3):339-47. PubMed ID: 20832994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of renal hemodynamic effects of nesiritide in patients with heart failure using intravascular Doppler and quantitative angiography.
    Elkayam U; Akhter MW; Liu M; Hatamizadeh P; Barakat MN
    JACC Cardiovasc Imaging; 2008 Nov; 1(6):765-71. PubMed ID: 19356514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and neurohumoral responses to intravenous nicorandil in congestive heart failure in humans.
    Giles TD; Pina IL; Quiroz AC; Roffidal L; Zaleski R; Porter RS; Karalis DG; Mohrland JS; Wolf DL; Hearron AE
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):572-8. PubMed ID: 1280713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic action of nicorandil in chronic congestive heart failure.
    Solal AC; Jaeger P; Bouthier J; Juliard JM; Dahan M; Gourgon R
    Am J Cardiol; 1989 Jun; 63(21):44J-48J. PubMed ID: 2525325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure.
    Tsutamoto T; Kinoshita M; Hisanaga T; Maeda Y; Maeda K; Wada A; Fukai D; Yoshida S
    Am J Cardiol; 1995 Jun; 75(16):1162-5. PubMed ID: 7762505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute hemodynamic effects of intravenous recombinant human brain natriuretic peptide in patients with acute myocardial infarction complicated with heart failure].
    Li SQ; Fu XH; Liu J; Gu XS; Zhang J; Fan XN; Jiang YF; Miao Q
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):23-7. PubMed ID: 16626544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of oral nicorandil in congestive heart failure.
    Tice FD; Binkley PF; Cody RJ; Moeschberger ML; Mohrland JS; Wolf DL; Leier CV
    Am J Cardiol; 1990 Jun; 65(20):1361-7. PubMed ID: 2140489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of hemodynamic tolerance to nicorandil in patients with severe congestive heart failure.
    Tsutamoto T; Kinoshita M; Nakae I; Maeda Y; Wada A; Yabe T; Horie H
    Am Heart J; 1994 Apr; 127(4 Pt 1):866-73. PubMed ID: 8154425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intravenous nicorandil on the mid-term prognosis of patients with acute heart failure syndrome.
    Ishihara S; Koga T; Kaseda S; Nyuta E; Haga Y; Fujishima S; Ishitsuka T; Sadoshima S
    Circ J; 2012; 76(5):1169-76. PubMed ID: 22447009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of tolerance to intravenous nitroglycerin during nicorandil and intermittent nitroglycerin patch in healthy volunteers.
    Tabone X; Funck-Brentano C; Billon N; Jaillon P
    Clin Pharmacol Ther; 1994 Dec; 56(6 Pt 1):672-9. PubMed ID: 7995010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure.
    Gheorghiade M; Blair JE; Filippatos GS; Macarie C; Ruzyllo W; Korewicki J; Bubenek-Turconi SI; Ceracchi M; Bianchetti M; Carminati P; Kremastinos D; Valentini G; Sabbah HN;
    J Am Coll Cardiol; 2008 Jun; 51(23):2276-85. PubMed ID: 18534276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of intracoronary nicorandil as hyperaemic agent for invasive physiological assessment: a patient-level pooled analysis.
    Lee JM; Kato D; Oi M; Toyofuku M; Takashima H; Waseda K; Amano T; Kurita A; Ishihara H; Lim WH; Doh JH; Nam CW; Tanaka N; Koo BK; Tanaka N
    EuroIntervention; 2016 Jun; 12(2):e208-15. PubMed ID: 27290680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good.
    Varriale P; Ramaprasad S
    Pharmacotherapy; 1997; 17(2):371-4. PubMed ID: 9085331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of nicorandil in congestive heart failure.
    Galié N; Varani E; Maiello L; Boriani G; Boschi S; Binetti G; Magnani B
    Am J Cardiol; 1990 Feb; 65(5):343-8. PubMed ID: 2137279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.